Strain of lactic acid bacteria with probiotic activity

Patent protecting a selected strain of lactobacillus with strong probiotic activity and a high capacity to produce specific beneficial compounds. The strain can be used in medical applications and as an ingredient in dietary supplements aimed at supporting health and well-being.

Patent title Ceppo di batterio lattico
Thematic area Bioeconomy, Agriculture and Environment
Ownership ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA, DEPOFARMA SPA
Inventors Beatrice Vitali, Davide Gottardi, Asia Pizzi, Carola Eleonora Parolin, Rosalba Lanciotti, Francesca Patrignani
Protection Italy, with the possibility of international extension
Licensing status Available for development agreements, options, licenses, and other commercialization agreements.
Keywords Lactobacilli, Prebiotics, Dietary Supplements
Filed on 18 April 2025

Currently, lactic acid bacteria with probiotic properties are the focus of numerous studies for their potential use in the food and medical fields. However, practical application is still limited due to differences between strains, difficulties in maintaining their viability and activity during processing and storage, and a still partial understanding of their mechanisms of action. For this reason, there is strong interest in selecting natural strains that are more stable, effective, and suitable for industrial use.

Specific strain of lactic acid bacteria with beneficial properties, usable in medical, nutraceutical, and food fields. It includes compositions for the treatment of gastrointestinal and neuro-gastrointestinal disorders, as well as for maintaining intestinal microbiota balance.

Applications:

  • Treatment and prevention of gastrointestinal and neurogastrointestinal disorders.
  • Dietary supplementation for intestinal well-being.
  • Industrial production of bioactive compounds.

Advantages:

  • Naturally efficient strain.
  • Easy to store and use.
  • Versatile application in medical and nutritional fields.
Page published on: 24 July 2025